ÂÜÀòÂÒÂ×

Francisco Guzman is a Principal Scientist currently at AbbVie since August 2024, with previous experience as a Principal Scientist at Cerevel Therapeutics from March 2023 to September 2024. Prior roles at Merck include Senior Scientist, Scientist, and Associate Scientist in Engineering from April 2013 to March 2023, alongside a stint as an MMDP Analyst - Associate Specialist in Engineering. Francisco began a research career as a Research Associate at The City College of New York’s Surface and Nanoparticle Engineering Group from January 2010 to 2012. Francisco's foundational experience included serving as an Aviation Boatswains Mate (Handler) in the United States Navy from September 2000 to July 2008. Francisco holds a Bachelor of Engineering degree in Chemical Engineering from The City College of the City University of New York, obtained between 2008 and 2012.